Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
April 25, 2024 ARS

An annual report to security holders

View HTML
April 23, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
April 16, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
March 28, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 15, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024 10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2024 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2024 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2024 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us